Trial Profile
Aprepitant: gastrointestinal system effects in healthy volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Pharmacodynamics
- 09 Nov 2015 New trial record